AAA
Affinity Asset Advisors’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-20,000
| Closed | -$2.52M | – | 84 |
|
|
2023
Q4 | $2.52M | Sell |
20,000
-26,400
| -57% | -$3.33M | 0.46% | 46 |
|
|
2023
Q3 | $4.34M | Sell |
46,400
-11,360
| -20% | -$1.06M | 1.22% | 22 |
|
|
2023
Q2 | $5.16M | Buy |
57,760
+17,760
| +44% | +$1.59M | 1.8% | 16 |
|
|
2023
Q1 | $4.29M | Sell |
40,000
-30,997
| -44% | -$3.32M | 1.42% | 21 |
|
|
2022
Q4 | $8.67M | Sell |
70,997
-29,003
| -29% | -$3.54M | 3.4% | 4 |
|
|
2022
Q3 | $10.3M | Sell |
100,000
-25,087
| -20% | -$2.59M | 2.88% | 6 |
|
|
2022
Q2 | $11.6M | Buy |
125,087
+5,087
| +4% | +$473K | 4.9% | 5 |
|
|
2022
Q1 | $14.1M | Buy |
+120,000
| New | +$14.1M | 2.25% | 4 |
|
|
2021
Q4 | – | Sell |
-35,910
| Closed | -$5.72M | – | 48 |
|
|
2021
Q3 | $5.72M | Buy |
35,910
+15,910
| +80% | +$2.54M | 1.45% | 15 |
|
|
2021
Q2 | $2.63M | Hold |
20,000
| – | – | 0.94% | 21 |
|
|
2021
Q1 | $2.58M | Buy |
20,000
+10,000
| +100% | +$1.29M | 0.88% | 26 |
|
|
2020
Q4 | $1.67M | Buy |
+10,000
| New | +$1.67M | 0.88% | 26 |
|